Funding Opportunities

Grants

New Nestlé Foundation Research Grants

The Nestlé Foundation offers different award and grant categories, some of them using a modular approach, i.e. the Pilot Grant Program represents the starting grant module for a later Full Grant Research application. The eligibility criteria as well as the Research objectives and topics have to be fulfilled independently from the award category (for further details see section “Specific information for applications”):

Training Grant
Pilot Grant
Full Grant (small / large)

At present the Foundation’s work is primarily concerned with human nutrition research issues dealing with:

maternal and child nutrition, including breastfeeding and complementary feeding,
macro- and micronutrient deficiencies and imbalances,
interactions between infection and nutrition, and
nutrition education and health promotion.

Due date for Letter of Intent: N/A

For more information click; https://www.nestlefoundation.org/research.html

New Next Generation Grants

SD CFAR’s Next Generation grants are designed for postdoctoral fellows supported by T32, D43, and R25 awards. These grants provide critical funds to help fellows collect and analyze data in support of their CDA applications. Up to $10,000 in direct costs may be requested for a one-year Next Generation grant.

Due date: Applications are accepted until the annual budget for these awards has been allocated.

For more information, click: https://cfar.ucsd.edu/en/grants/next-generation/

Gut Microbiota International Call for Projects

The Biocodex Microbiota Foundation founds research projects focused on human gut microbiota related to health and disease. Every year, the call for proposals covers a specific theme chosen by an International Scientific Committee. Either clinical or fundamental research proposals can be submitted. The maximal duration of the project will be 3 years.The grant is open to physicians, PhD’s and Pharm-D’s working in the subject area (gastroenterology, pediatrics, microbiology, infectious diseases and internal medicine, etc).There are no geographic limitations of applicants. Candidates from all countries are potentially eligible. A principal investigator having already received a Biocodex Microbiota Foundation international grant cannot apply anymore. However, principal investigator of a National Grant can apply for the International Grant.

The annual grant is set at €200,000 VAT included, independently of the duration of the project (between 1 and 3 years).

Due date: 30 November 2025 (24:CET)

For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects

Early-Career Scientific Research Grants Program

The AABB Foundation awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine and biotherapies. Grant applications are evaluated on the basis of their scientific merit, relevance to and impact on transfusion medicine, focus and appropriateness to the scope of funding, and likelihood of yielding meaningful data.

Due date: 1 December 2025

For more information click: https://www.aabb.org/foundation/early-career-scientific-research-grants-program

Path to a Cure — Pioneer Award

The goal of this request for applications is to identify ambitious basic research projects aiming to utilize cutting-edge techniques and strategies that have the potential to discover new genetic-based therapies for cystic fibrosis. This award is intended for exceptional investigators who have made significant, impactful contributions to their field of research. Academic programs supported through the Path to a Cure: Pioneer Award will focus on two core strategies to address the underlying cause of cystic fibrosis:

Restoring CFTR protein
Targeting the Root Cause of Disease

Due date: 5 December 2025

For more information click; https://www.cff.org/researchers/path-cure-pioneer-award

RARE Grant Program – Research Accelerating RUNX1 Exploration

The purpose of the grant is to fund research that will accelerate the discovery of druggable oncogenic pathways and deliver cancer interception and cancer prevention therapeutics for RUNX1-FPD children and family members. The RARE Grant is a two-year award designed to fund research that will lead to the development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevent blood cancer (before clonal hematopoiesis). The RUNX1 Research Program hosts an annual scientific conference and patient meeting that brings together grant recipients and other scientists. Grant recipients are expected to present their progress as part of the annual review.

Due date: 11 December 2025, 8pm ET

For more information click: https://www.alexslemonade.org/researchers-reviewers/applicants

New Mental Health Research Fellowships

The charity MQ Mental Health Research is accepting expressions of interest for their 2026 Fellows programme. These grants offer up to £250,000 over three years for early career mental health researchers asking challenging questions about children and young peoples mental health, self-harm and suicide, eating disorders and digital innovations for mental health

Due date: 12 December 2025

For more information click: https://www.mqmentalhealth.org/our-work/research-programmes/fellows-award/

Spencer Foundation Research Grants on Education: Small

The Small Research Grants on Education Program supports education research projects that will contribute to the improvement of education, broadly conceived, with budgets up to $50,000 for projects ranging from one to five years. We accept applications two times per year. This program is “field-initiated” in that proposal submissions are not in response to a specific request for a particular research topic, discipline, design, method, or location. Our goal for this program is to support rigorous, intellectually ambitious and technically sound research that is relevant to the most pressing questions and compelling opportunities in education.

Due date: December 15, 2025, 12:00 pm (noon), Central Time

For more information click: https://www.spencer.org/grant_types/small-research-grant

New Gates Foundation – Accelerating Innovation in Vaginal Formulations in Support of Women’s Health

We are soliciting applications that contribute to development of vaginal formulations that promote optimal drug delivery within the vaginal compartment while positively supporting the vaginal milieu, and that also possess beneficial effects, even if unrelated to the API intended effect, that a user might consider desirable, such as enhancement of sexual pleasure. We anticipate identifying product-agnostic features that promote vaginal health and that broadly appeal to women to advance product development and formulations for women’s health. We welcome innovations at any stage of development that meet the scope of this call.

Applicants may apply to address one or more of the following objectives of this challenge:

Leverage biology for vaginally administered products
Define characteristics of an ideal vaginal product

Projects with a duration of up to two years and a maximum requested budget of $250,000USD are eligible for funding. Exploratory projects with shorter durations/lower budgets that focus on high-risk, innovative areas are strongly encouraged and will be given priority.

Due date: 16 December 1700HRS, East African Time (EAT)

For more information, click: https://gcgh.grandchallenges.org/challenge/accelerating-innovation-vaginal-formulations-support-womens-health-2

New Gates Foundation – Accelerating Development of Innovative, Exceptionally Low-Cost Maternal and Child Nutrient Ingredients and Products

We are not seeking incremental improvements. This call is for transformative, bold solutions that can reduce costs by at least 50% compared to current baselines, while maintaining or improving safety, efficacy, and user acceptability. We want to support the development and validation of scalable, sustainable strategies that make high-quality nutrient ingredients and products affordable for LMIC health systems and ensure equitable access for every mother and child. Based on Latham BioPharm Group research, the commonly available pharmaceutical quality ingredients for the nutrients of interest are calcium carbonate, choline bitartrate, choline chloride, and algal DHA powder. The lowest prices reported are 2.1 USD/kg, 5.8 USD/kg, 1.2 USD/kg, and 52 USD/kg (30% purity) respectively. The target cost for exceptionally low-cost nutrient ingredients should be at least 50% below the lowest price identified.

Due date: 16 December 2025, 11:30 am PST

For more information, click: https://gcgh.grandchallenges.org/challenge/accelerating-development-innovative-exceptionally-low-cost-maternal-and-child-nutrient

Apply for Funding from the CMT Research Foundation

The mission of the CMT Research Foundation is to deliver treatments and cures for CMT during our lifetime. The CMT Research Foundation pursues this goal by identifying and bridging the gaps in biomedical research, with a focus on areas that are most likely to result in clinical treatments. Funding is provided to the most promising research for CMT that leads to the development of therapeutics for all types of CMT. The research priorities drive funding decisions, however, if an interesting approach or idea, they would want to hear from you.

Before submitting a full proposal, applicants must first submit a Letter of Intent.

Full proposals are accepted on a quarterly basis, with submission deadlines as follows:

Q1: December 17, 2025

Q2: February 18, 2026

Q3: May 20, 2026

Q4: August 12, 2026

LOIs submitted less than 6 weeks prior to these deadlines may be shifted to the next cycle for consideration at the Research Team’s discretion.

For more information click: https://cmtrf.org/apply/

Melvin Yahr Parkinson’s Disease Clinical Research Award

The Melvin Yahr Parkinson’s Disease Clinical Research Award is jointly supported by the Parkinson’s Foundation and the International Association of Parkinsonism and Related Disorders (IAPRD). This award is designed to foster clinical research into any aspect of Parkinson’s disease conducted by young investigators who are under-represented in current research. By recognizing and honoring the exceptional contributions of young talented individuals, the award seeks to break down barriers and create a more inclusive and diverse healthcare community. It is expected that this initiative will spur innovation and promote the translation of cutting-edge scientific discoveries into efficient and practical health measures that will benefit people with Parkinson’s disease. The goal of the award is to prepare young neurologists specializing in Parkinson’s disease for a career in clinical research. Clinician scientists are uniquely positioned to be experts in both Parkinson’s disease research and care.

Due date: 12 January 2026

For more information click: https://www.parkinson.org/advancing-research/for-researchers/fellowships-early-career-awards#Melvin

New Cure Parkinson’s Quarterly Research Grant Funding Programme

Cure Parkinson’s (CP) has opened its Quarterly Open Funding Round to support innovative research projects aimed at finding a cure for Parkinson’s disease. The focus areas include laboratory or clinical research projects with the potential to cure Parkinson’s, disease-modifying therapy or therapies, research with the potential to prevent, slow, stop, or reverse the underlying disease progression, and projects that prioritise those living with Parkinson’s now. CP funds both preclinical and clinical research. For preclinical research, grants of up to £250,000 are available, prioritising projects that can lead to clinical trials within five years. Clinical research funding covers trials and sub-studies involving people with Parkinson’s, with flexible grant amounts.

Due date: 12 January 2026

For more information click; https://cureparkinsons.org.uk/research/for-researchers/apply-for-funding/quarterly-research-grant/

New Call for Applications: International Development Grant Program

The Society for the Advancement of Behavior Analysis is accepting applications for its International Development Grant Program for individuals and organizations for the development and/or dissemination of behavior analysis internationally. Support persons or organizations interested in developing behavior analysis internationally. To promote behavior analysis worldwide, it is hoped that the opportunities for people and organizations that do not have the necessary resources to expand important information and knowledge will be increased. The grant program provides financial support ranging from US$1,000 to US$5,000 for projects focused on developing behavior analysis on an international scale.

Due date: 14 January 2026

For more information click; https://saba.abainternational.org/grants/International-Development-Grant

New E.W. “Al” Thrasher Awards

E.W. “Al” Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority. Hypothesis-driven research is critical, exploratory, or hypothesis-generating research will not be competitive. For projects focused on improving disease diagnosis, please ensure that there are well researched, effective treatment options available to patients upon diagnosis.

Concept Submission Deadline: January 13, 2026 (Noon Mountain Time)

For more information click; https://www.thrasherresearch.org/al-thrasher-award?lang=eng

Emerging Researcher Award (ERA) Pilot Grants

The CMT Research Foundation values bringing fresh talent and thinking into the CMT research arena. To enable this, the ERA Pilot Grants are intended to support early-career researchers in the conduct of research projects aimed at testing innovative ideas to expand and advance drug development for Charcot-Marie-Tooth (CMT) disease. Awards will be prioritized to applicants that propose research projects with strong scientific merit and high potential to result in further research related to CMT drug development. For successful projects, follow-on funding from CMTRF may be a possibility. These grants specifically encourage the exploration of new ideas or concepts that are not currently or previously funded or explored.

OPTIONAL: Letter Of Intent submissions: 15 November 2025

Due date: January 30, 2026

For more information click: https://cmtrf.org/research/emerging-researcher-award/

New Gilead

Gilead welcomes funding requests for innovative, high impact projects that relate to at least one of our core therapeutic areas: Our grantmaking in Africa focuses on the following therapeutic areas: HIV/AIDS; Viral Hepatitis. Within these therapeutic areas, we provide support for a broad range of activities, including: Disease awareness; Disease prevention; Professional education; Improving patient access to care; Improving quality of care; Increasing scientific capacity; Strengthening healthcare systems. Funding requests must be submitted a minimum of 8 weeks prior to the start of the activity. The typical grant review timeline can be up to 12 weeks. Formal notifications of all funding decisions are sent in writing by email to the contact listed on the grant application.

Due date: Grant applications are accepted throughout the year.

For more information, click: https://www.gilead.com/responsibility/giving-at-gilead/corporate-giving/how-to-apply-for-funding

IMS Career Development Award

The International Myeloma Society is proud to announce the sixth annual “IMS Career Development Award”. The IMS anticipates funding grants for young investigators focused on research in the field of plasma cell dyscrasias. Goal: To promote the development of the next generation of leaders in the field of plasma cell disorders. This award will also encourage interaction between institutions to enhance collaborative research.

Due date: January 30, 2026 at 11:59 pm EST.

For more information, click: https://www.myelomasociety.org/grants/ims-career-development-award/

Wellcome Early-Career Awards

This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.

Due date: 17 February 2026, 15:00 GMT

For more information, click: https://wellcome.org/research-funding/schemes/wellcome-early-career-awards

New RFAs: Profound Autism Pilot Grant and Pre-Doctoral Fellowship Program

The Autism Science Foundation (ASF) is accepting applications for its Profound Autism Pilot Grant and Pre-Doctoral Fellowship Program, supporting research focused on the unique needs of individuals with profound autism. Funding is available for one-year pilot studies and pre-doctoral training projects that explore biological mechanisms, treatments, co-morbidities, and methodological challenges.

Due date: 6 March 2026

For more information click; https://autismsciencefoundation.org/apply-for-a-profound-autism-pilot-grant/

New Clinical Cancer Research

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) supports truly innovative and unique patient-centered clinical trials that have the potential to positively impact the lives of cancer patients. Our overall goal is to improve treatment options and quality of life for cancer patients by funding studies focused on detection, treatment, and survivorship. We fund phase I to phase III interventional clinical trials. We do not fund, however, basic research, phase IV trials, or observational or epidemiological studies.

Due dates: Letter of Intent is due March 9th, 2026

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

New Genomics in Context Awards: collaborative research at the intersection of genomics, humanities, social sciences and bioethics

These awards will support transdisciplinary teams to catalyse research discoveries at the intersection of genomics, humanities, social sciences and bioethics. Funded projects will be given the time and resources to create new research agendas and explore innovative ways of working. The importance of social, ethical and legal work for guiding ethical, inclusive genomics research and related practices is widely acknowledged. Less recognised is the underexplored potential for the intersection between genomics, humanities and social sciences, and wider societal partners (including industry, policymakers and communities) to yield new research and discoveries. To date such collaborations have tended to be limited and late. This call is aimed at supporting novel and transdisciplinary teams to explore this intersection at the earliest stages of research ideation, design and partnership building. Collaborations could take many different forms and centre on a variety of areas of focus.

Due date: 16 March 2026

For more information, click: https://wellcome.org/research-funding/schemes/genomics-in-context-awards

New Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from low- and middle-income country (LMIC) and U.S. institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research (not including HIV/AIDS). FIC will support research training programs that focus on 1) major endemic or life-threatening emerging infectious diseases, 2) neglected tropical diseases, 3) infections that frequently occur as co-infections in HIV infected individuals or 4) infections or microbiomes associated with non-communicable disease conditions of public health importance in LMICs. Advanced scientific training related to prevention, treatment or public health approaches to any technical area of basic, epidemiological, clinical, behavioral or social science health research may be supported. Research training programs should incorporate didactic, mentored research and professional development skills components to prepare individuals for sustainable careers that will have significant impact on the priority health research needs of LMICs.

Due date: 6 August 2026

For more information click: https://grants.nih.gov/grants/guide/pa-files/PAR-24-174.html

Fellowships and Scholarships

New International AIDS Society Scholarship applications are open

If you are at least 18 years old on 26 July 2026 and working, volunteering or studying in the area of HIV, you are welcome to apply for a scholarship for AIDS 2026. The IAS will award both in-person and virtual scholarships for AIDS 2026. Please select your preferred attendance type in your application, as well as the types of financial support you require to participate.

Due date: 27 January 2026 , 23:59 CET

For more information click: https://www.iasociety.org/conferences/aids2026/take-part/scholarships

New ANSO-CAS-TWAS/UNESCO PhD Scholarship

According to an agreement between the Alliance of International Science Organizations (ANSO), the Chinese Academy of Sciences (CAS) and The World Academy of Sciences (TWAS/UNESCO) for the advancement of science in developing countries, up to 40 students/scholars from developing countries will be sponsored to study in China for doctoral degrees for up to 4 years.

Due date: 31 January 2026

For more information click; https://twas.org/opportunity/anso-cas-twasunesco-phd-scholarship

The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship)

The SAHRI Fellowship programme empowers a new generation of skilled researchers to address critical gaps in health research and innovation in sub-Saharan Africa. The sub-Saharan Africa Health Research and Innovation Fellowship (SAHRI Fellowship) programme is an exceptional three-year training trajectory designed to empower 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa (sSA) to become leaders in biomedical innovation and clinical research, tackling the urgent challenges of infectious disease prevention, diagnosis, treatment, and control across the region. The fellowship is fully funded by a grant from the Global Health EDCTP3 and implemented by a consortium of academic and research institutions from Europe and Africa, led by the Institute of Tropical Medicine Antwerp in collaboration with BioNTech.

Deadline for the 2026-2029 cohort: 1 February 2026

For more information, click: https://www.itg.be/en/research/projects/the-sub-saharan-africa-health-research-and-innovation-fellowship-program-sahri-fellowship?trk=public_post_comment-text

New Newton International Fellowship

The Newton International Fellowship (NIF) programme provides support for outstanding early career researchers to make a first step towards developing an independent research career through gaining experience across international borders. The fellowships enable researchers to access expertise, gain new perspectives and build long-lasting collaborative relationships. This scheme is jointly run by the British Academy and the Royal Society. The overarching aim of the Newton International Fellowship programme is to attract and retain emerging talent in the UK and build a globally connected, mobile research and innovation workforce. The objectives are to:

Attract talented international early career researchers to establish and conduct their research in the UK
Support early career researchers to pursue high-quality and innovative lines of research
Provide opportunities to acquire new skills and knowledge through training and career development
Foster long-term relationships through networking opportunities and the Newton International Fellowships alumni programme.

Due date: Open date 15 January 2026 and close date 11 March 2026

For more information click: https://royalsociety.org/grants/newton-international/

Path to a Cure — Pioneer Award

Restoring CFTR protein
Targeting the Root Cause of Disease

Due date: 5 December 2025

For more information click; https://www.cff.org/researchers/path-cure-pioneer-award

Spencer Foundation Research Grants on Education: Small

Due date: December 15, 2025, 12:00 pm (noon), Central Time

For more information click: https://www.spencer.org/grant_types/small-research-grant

New Genomics in Context Awards: collaborative research at the intersection of genomics, humanities, social sciences and bioethics

Applications open 11 November 2025

Due date: 16 March 2026

For more information, click: https://wellcome.org/research-funding/schemes/genomics-in-context-awards

New DKMS John Hansen Research Grant 2026

This is a Grant for the study of hematopoietic stem cell transplantation and cell therapy for hematological diseases. In honor of John A. Hansen, this grant is intended to provide financial support to promising young researchers to advance the understanding of complications and therapeutic strategies in the context of hematological diseases. The grant is funded by the foundation DKMS Stiftung Leben Spenden and administered by the DKMS Group gGmbH. The research proposal needs to address issues on hematopoietic stem cell transplantation or cell therapy for hematological diseases. Various aspects can be covered, including but not limited to: diagnostic and therapeutic strategies, transplant immunology, stem cell transplantation complications, donor selection, or cell manufacturing.

Due date: November 20, 2025, 23:59h (Central European Time).

For more information click: https://professional.dkms.org/research-publications/research-grant

New Early-Career Scientific Research Grants Program

Due date: 1 December 2025

For more information click: https://www.aabb.org/foundation/early-career-scientific-research-grants-program

New RARE Grant Program – Research Accelerating RUNX1 Exploration

Due date: 11 December 2025, 8pm ET

For more information click: https://www.alexslemonade.org/researchers-reviewers/applicants

New Apply for Funding from the CMT Research Foundation

Before submitting a full proposal, applicants must first submit a Letter of Intent.

Full proposals are accepted on a quarterly basis, with submission deadlines as follows:

Q1: December 17, 2025

Q2: February 18, 2026

Q3: May 20, 2026

Q4: August 12, 2026

LOIs submitted less than 6 weeks prior to these deadlines may be shifted to the next cycle for consideration at the Research Team’s discretion.

For more information click: https://cmtrf.org/apply/

New Melvin Yahr Parkinson’s Disease Clinical Research Award

Due date: 12 January 2026

For more information click: https://www.parkinson.org/advancing-research/for-researchers/fellowships-early-career-awards#Melvin

New Emerging Researcher Award (ERA) Pilot Grants

OPTIONAL: Letter Of Intent submissions: 15 November 2025

Due date: January 30, 2026

For more information click: https://cmtrf.org/research/emerging-researcher-award/

New Emerging Researcher Award (ERA) Predoctoral Grants

ERA Predoctoral Grants are intended to support promising predoctoral fellows in the conduct of research projects aimed at testing new and innovative ideas that will expand or advance drug development for Charcot-Marie-Tooth (CMT) disease. Awards will be prioritized to applicants that propose research projects with strong scientific merit and high potential to result in further research related to CMT drug development. For successful projects, follow-on funding from CMTRF may be a possibility.

OPTIONAL: Letter Of Intent submissions: 15 November 2025

Due date: January 30, 2026

For more information click: https://cmtrf.org/research/emerging-researcher-award/

New IMS Career Development Award

Due date: January 30, 2026 at 11:59 pm EST.

For more information, click: https://www.myelomasociety.org/grants/ims-career-development-award/

New Wellcome Early-Career Awards

Due date: 17 February 2026, 15:00 GMT

For more information, click: https://wellcome.org/research-funding/schemes/wellcome-early-career-awards

Fellowships and Scholarships

New The Ibrahim Leadership Fellowships

The Ibrahim Leadership Fellowships were established in 2011 to identify and mentor the future generation of outstanding African leaders. Each year three Fellows have an opportunity to work in the executive offices of the AfDB (Abidjan), ECA (Addis Ababa) or the ITC (Geneva), with a stipend of $100,000. During their 12-month programmes, Fellows gain both technical and leadership skills, while contributing directly to research and policy design. A special feature of the programme is the opportunity to benefit from the direct mentorship of the heads of the host organisations. Fellows also become members of the Now Generation Network (NGN), through which they continue to contribute their skills and insights to building a better Africa.

Due date: 20 November 2025

For more information click: https://mo.ibrahim.foundation/fellowships

New Harvard Learn, Engage, Advance, Disrupt “LEAD” Fellowship for Promoting Women in Global Health

To equip and empower more leaders in global health, the Harvard Global Health Institute, in collaboration with the Department of Global Health and Population at Harvard T.H. Chan School of Public Health, offers a transformational 1-year fellowship specifically designed to promote leadership skills in individuals from low- and middle-income countries who will, in turn, mentor future female leaders in global health.

Deadline for the 2026-2027 cohort: November 30th, 2025, 11:59PM EST.

For more information, click: https://globalhealth.harvard.edu/fellowships/harvard-lead-fellowship/#LEAD-Fellowship

New McDonald Fellowship

MSIF’s McDonald Fellowships fund 2-year research placements for early career researchers from low- and middle-income countries. The McDonald Fellowship enables early career multiple sclerosis researchers from low- and middle-income countries to work in a research institution outside of their own country. During the visit, participants either gain expertise or carry out parts of joint research projects. Following the award, we expect applicants will be able to use the newly developed expertise and networks, continuing to undertake MS research and/or patient care in low- and middle-income countries. The fellowship payment is a two-year grant, consisting of 55,000 EUR per year, paid to the host institution and then used to pay the fellow. One return flight to the host country will also be covered by the Fellowship.

Due date: 1 December 2025

For more information click: https://www.msif.org/research/awards-grants-and-fellowships/mcdonald-fellowships/

New The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship)

Deadline for the 2026-2029 cohort: 1 February 2026

For more information, click: https://www.itg.be/en/research/projects/the-sub-saharan-africa-health-research-and-innovation-fellowship-program-sahri-fellowship?trk=public_post_comment-text

Trainings

New Human Gut Microbiome Metagenomics – Africa

This intensive training course is a collaboration between Wellcome Connecting Science, the Wellcome Sanger Institute, and the KEMRI-Wellcome Trust, and will provide early career researchers and scientists with cutting-edge skills in microbiome study design, sequencing, bioinformatics data analysis, and data interpretation. The course uses a blended learning model over three months, including pre-course modules, a 6-day residential workshop at KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya (12–17 April 2026), and post-course mentoring and networking activities. The residential workshop will combine lectures, hands-on sessions, seminars, and discussions, progressing from fundamentals of microbiome metagenomics to applied data analysis and interpretation and professional development.

Due date: 03 November 2025

For more information, click: https://coursesandconferences.wellcomeconnectingscience.org/event/human-gut-microbiome-metagenomics-africa-20260412/?dm_i=6Y2C,2QNE3,1GUODO,7M5MJ,1

New Antimicrobial Resistance of Bacterial Pathogens – Africa

n collaboration with the National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Services, Johannesburg, South Africa, we are pleased to announce our 2026 global training course in AMR of bacterial pathogens in Africa. This course aims to address regionally specific AMR-associated challenges through knowledge transfer and skills development by global experts. This week-long course will include an introduction to AMR with hands-on laboratory practicals for AMR detection through molecular and phenotypic testing accompanied by theoretical training on the evolution and spread of AMR and utilisation of whole-genome sequencing and bioinformatics analysis methods for AMR surveillance and control. It will also provide an opportunity for participants to network and potentially build a regional AMR community to support long-term partnerships and collaborations.

Due date: 03 November 2025

For more information, click: https://coursesandconferences.wellcomeconnectingscience.org/event/antimicrobial-resistance-of-bacterial-pathogens-africa-20260307/?utm_source=dotdigital&utm_medium=email&utm_campaign=amrafrica2026-email&utm_id=amrafrica2026&dm_i=6Y2C,2QNE3,1GUODO,7M5MJ,1

Colorectal Cancer Alliance PROJECT CURE CRC

The Colorectal Cancer Alliance (the Alliance) is pleased to announce a Request for Proposals (RFP) for preclinical, translational and clinical research with the potential for high impact on treatment and survivorship of colorectal cancer. Project Cure CRC will prioritize proposals that embrace moving colorectal cancer research to a curative science ASAP. Submitted proposals should focus on projects that are High-Risk/High-Reward and accelerate new therapies and technologies from bench to bedside. Projects that utilize collaborations and/or public-private partnerships are STRONGLY encouraged. Proposals will be accepted for Early-Career Investigator Awards, Senior Investigator Awards, Pilot Awards, Team Science Awards, and Opportunistic Awards from academic and industry researchers. The Alliance plans to award tens of millions in 2025 for new research and infrastructure needs arising from this RFP.

Types of Awards;

Young Investigator Accelerator Award (Academic and Non-profit Applicants Only)
Senior Investigator Accelerator Award (Academic and Non-profit Applicants Only)
Pilot Accelerator Award (Academic, Non-profit or Industry Applicants)
Team Science Accelerator Award (Academic, Non-profit and/or Industry)

Due date: There are no application deadlines. Applications will be accepted on a rolling basis starting on January 25th. A response regarding your proposal submission will be provided within two months of submission.

For more information, click; https://colorectalcancer.org/sites/default/files/media/documents/PRTMPL143852.PDF

Mental Health Award: Transforming early intervention for anxiety, depression and psychosis in young people

Funding for projects that robustly test the real-world effectiveness and assess implementation strategies of scalable transformative early interventions for anxiety, depression and psychosis in young people. This award is structured in two phases: a Foundation Phase followed by an Impact Phase;

Foundation Phase – This first phase of the funding call will provide teams with £200,000 to build their teams and develop their detailed proposal for their research study over 12 months. This research proposal must be for a definitive effectiveness study and assessment of strategies for implementation and scaling of a psychological and/or a social intervention. The proposal must capture multiple outcomes that are relevant to people with lived experience and implementing partners, including mental health outcomes, functional outcomes and full economic evaluation.

Impact Phase (open to applications February 2027).

In the second phase of the funding call, all teams from the Foundation Phase will be invited to apply for the Impact Phase. We expect the award amount for the Impact Phase to be between £5 million and £8 million and the duration to be up to 5 years. The upper limits will be confirmed during the Foundation Phase.

Due date foundation stage: 11 November 2025

For more information click; https://wellcome.org/research-funding/schemes/mental-health-award-transforming-early-intervention#application-process-timeline-c42e

New ICPO Research Call for “AI-driven advancements in Precision Oncology“

The International Centers for Precision Oncology (ICPO) Foundation is committed to advancing the field of precision oncology through the strategic integration of Artificial Intelligence (AI). Recognizing unique challenges in a wider clinical adoption of Theranostics, ICPO has structured a series of research calls designed to systematically address and leverage AI-based enhancements of oncology care. More specifically, this initiative underscores the potential of foundational data curation, innovative prediction model development, and clinical validation to realize the transformative potential of AI in clinical oncology. This is a 3 year call series starting in 2025. To support the development of methodologies for curating and standardizing theranostics datasets—both imaging and non-imaging—by producing a structured database framework and annotation approach. This call focuses on the creation of data models, curation standards, and maintenance methods, without the collection or sharing of data at this stage. Any indication relevant to theranostics can be included.

Due date: 1 November 2025

For more information, click; https://www.icpo.foundation/icpo-research/ai-call-for-applications/

New Wellcome Career Development Awards

This scheme provides funding for mid-career researchers from any discipline who have the potential to be international research leaders. They will develop their research capabilities, drive innovative programmes of work and deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 20 November 2025

For more information click; https://wellcome.org/research-funding/schemes/wellcome-career-development-awards

New Path to a Cure — Collaborative Research Grant

This program is intended to facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat cystic fibrosis with an emphasis on advancing CFTR gene repair and replacement approaches. Small molecule CFTR modulators that directly target the mutant protein are powerful therapies that will likely benefit 90% of people with CF in the near future. However, there is still a significant unmet need for people with CFTR mutations who do not respond to modulators, do not generate sufficient quantities of protein for correction, or block protein synthesis (i.e., premature stop codon mutations, splice site mutations, indels, etc.). To ensure all people with CF have access to effective CFTR-directed therapies, the Cystic Fibrosis Foundation announced the Path to a Cure initiative in 2019. Projects supported through the Path to a Cure: Collaborative Research Grant should be ambitious in scope and utilize cutting-edge technologies and strategies that have the potential to inform or translate into novel therapies to restore CFTR protein function by fixing and/or replacing the defective CFTR gene.

Due date: 20 November 2025

For more information click; https://www.cff.org/researchers/path-cure-collaborative-research-grant

New Wellcome Discovery Awards

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.

Due date: 25 November 2025, 15:00 GMT

For more information click; https://wellcome.org/research-funding/schemes/wellcome-discovery-awards

Clinical Cancer Research

Due dates: Letter of Intent is due November 23rd, 2025

For more information, click: https://www.risingtide-foundation.org/clinical-cancer-research-how-to-apply/

New Gut Microbiota International Call for Projects

The annual grant is set at €200,000 VAT included, independently of the duration of the project (between 1 and 3 years).

Due date: 30 November 2025 (24:CET)

For more information click; https://www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects

New Path to a Cure — Pioneer Award